PRAX Praxis Precision Medicines, Inc.
Price Chart
Executive Summary
Praxis Precision Medicines granted 2,754 restricted stock units to 13 new non-executive employees under its 2024 Inducement Plan, a routine equity inducement for new hires. The grant is immaterial in size relative to the company's $9.3B market cap and has no impact on operations or financials.
Actionable Insight
No trading action warranted. This is a routine equity inducement for new hires with negligible dilution. Monitor upcoming pipeline catalysts (late-stage CNS programs) for material events.
Key Facts
- Granted 2,754 RSUs to 13 new non-executive employees under the 2024 Inducement Plan
- Awards vest in four equal annual installments subject to continued employment
- Inducement grants are routine and comply with Nasdaq Listing Rule 5635(c)(4)
Financial Impact
2,754 shares granted; immaterial relative to $9.3B market cap
Risk Factors
- No material risk from this grant
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3305570 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
5d ago
|
Institutional Cluster
| $247.98 $266.58 | ▲ +7.50% | ▲ +6.96% | $257.25 (+3.74%) |
|
Jun 2, 2026
14d ago
|
Press Release
| $278.93 $264.75 | ▼ −5.08% | ▼ −5.49% | $257.25 (−7.77%) |
|
May 7, 2026
5w ago
|
Press Release
| $333.28 $330.02 | ▼ −0.98% | ▼ −1.81% | $257.25 (−22.81%) |
|
May 4, 2026
6w ago
|
Press Release
| $333.30 $338.07 | ▲ +1.43% | ▲ +0.05% | $257.25 (−22.82%) |
|
Apr 14, 2026
9w ago
|
Press Release
| $343.60 $339.93 | ▼ −1.07% | ▼ −1.84% | $257.25 (−25.13%) |
|
Apr 6, 2026
10w ago
|
Press Release
| $310.11 $306.69 | ▼ −1.10% | ▼ −1.17% | $257.25 (−17.05%) |
|
Mar 30, 2026
11w ago
|
Press Release
| $322.19 $319.28 | ▼ −0.90% | ▼ −1.65% | $257.25 (−20.16%) |
|
Feb 28, 2026
15w ago
|
Institutional Cluster
| $330.59 $318.22 | ▼ −3.74% | ▼ −2.83% | $257.25 (−22.18%) |
|
Feb 28, 2026
15w ago
|
Institutional Cluster
| $330.59 $318.22 | ▼ −3.74% | ▼ −2.83% | $257.25 (−22.18%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access